JPWO2022123070A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2022123070A5
JPWO2022123070A5 JP2023535468A JP2023535468A JPWO2022123070A5 JP WO2022123070 A5 JPWO2022123070 A5 JP WO2022123070A5 JP 2023535468 A JP2023535468 A JP 2023535468A JP 2023535468 A JP2023535468 A JP 2023535468A JP WO2022123070 A5 JPWO2022123070 A5 JP WO2022123070A5
Authority
JP
Japan
Prior art keywords
poly
polymersomes
population
peo
seq
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023535468A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024500360A (ja
JP2024500360A5 (https=
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2021/085366 external-priority patent/WO2022123070A1/en
Publication of JP2024500360A publication Critical patent/JP2024500360A/ja
Publication of JP2024500360A5 publication Critical patent/JP2024500360A5/ja
Publication of JPWO2022123070A5 publication Critical patent/JPWO2022123070A5/ja
Pending legal-status Critical Current

Links

JP2023535468A 2020-12-11 2021-12-13 関連づけられた抗原および関連づけられたアジュバントを有する2つのポリマーソーム集団を投与することによる、Th1/Th2免疫応答の調整方法 Pending JP2024500360A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP20213488.8 2020-12-11
EP20213488 2020-12-11
PCT/EP2021/085366 WO2022123070A1 (en) 2020-12-11 2021-12-13 Modulating th1/th2 immune response by administering two populations of polymersomes having an associated antigen and an associated adjuvant

Publications (3)

Publication Number Publication Date
JP2024500360A JP2024500360A (ja) 2024-01-09
JP2024500360A5 JP2024500360A5 (https=) 2024-07-11
JPWO2022123070A5 true JPWO2022123070A5 (https=) 2024-07-11

Family

ID=74187071

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023535468A Pending JP2024500360A (ja) 2020-12-11 2021-12-13 関連づけられた抗原および関連づけられたアジュバントを有する2つのポリマーソーム集団を投与することによる、Th1/Th2免疫応答の調整方法

Country Status (6)

Country Link
US (1) US20230398207A1 (https=)
EP (1) EP4259197A1 (https=)
JP (1) JP2024500360A (https=)
AU (1) AU2021396659A1 (https=)
CA (1) CA3193643A1 (https=)
WO (1) WO2022123070A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG10201704135QA (en) * 2012-11-19 2017-06-29 Agency Science Tech & Res Method For Eliciting An Immune Response To An Immunogen
EP4604997A2 (en) * 2022-10-21 2025-08-27 PDS Biotechnology Corporation Recombinant protein vaccines formulated with enantio-specific cationic lipid r-dotap and methods of use thereof

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5354934A (en) 1993-02-04 1994-10-11 Amgen Inc. Pulmonary administration of erythropoietin
EP2281033B1 (en) 2008-04-17 2014-10-15 Vin de Bona Trading Co Pte Post release modification of viral envelopes
US8323696B2 (en) 2008-08-29 2012-12-04 Ecole Polytechnique Federale De Lausanne Nanoparticles for immunotherapy
CN102460150B (zh) 2009-04-20 2015-05-20 新加坡科技研究局 囊泡系统及其用途
EP2601262A4 (en) 2010-08-05 2014-01-22 Agency Science Tech & Res VESIGN STRUCTURE WITH SEVERAL CHAMBERS AND METHOD FOR THEIR EDUCATION
CA2866170A1 (en) 2012-03-12 2013-09-19 Advanced Bioadjuvants, Llc Adjuvant and vaccine compositions
DK2906717T3 (en) 2012-10-11 2019-04-01 Vin De Bona Trading Company Pte Ltd PROCEDURE FOR PAINTING MICROVESICS
SG10201704135QA (en) 2012-11-19 2017-06-29 Agency Science Tech & Res Method For Eliciting An Immune Response To An Immunogen
KR101943171B1 (ko) * 2013-09-19 2019-01-29 조에티스 서비시즈 엘엘씨 유성 아쥬반트
EP2898894A1 (en) 2014-01-27 2015-07-29 LTS LOHMANN Therapie-Systeme AG Nano-in-micro particles for intradermal delivery
US9636397B2 (en) 2015-03-24 2017-05-02 VaxLiant, LLC Adjuvant compositions and related methods
US10696985B1 (en) * 2016-06-06 2020-06-30 Vanderbilt University Reversibly crosslinked endosomolytic polymer vesicles for cytosolic drug delivery
EP3743101A2 (en) * 2018-01-25 2020-12-02 ACM Biolabs Pte Ltd Polymersomes comprising a soluble encapsulated antigen as well as methods of making and uses thereof
CN114502191B (zh) * 2019-08-01 2026-04-03 Acm生物实验室私人有限公司 通过施用具有关联的抗原的聚合物囊泡群和具有关联的佐剂的聚合物囊泡群来引发免疫应答的方法以及包含这两种聚合物囊泡群的组合物
US20230256082A1 (en) * 2020-04-24 2023-08-17 Acm Biolabs Pte Ltd Vaccine against human-pathogenic coronaviruses

Similar Documents

Publication Publication Date Title
JPWO2021019102A5 (https=)
US11235069B2 (en) Use of liposomes in a carrier comprising a continuous hydrophobic phase for delivery of polynucleotides in vivo
US20080124350A1 (en) Nanoparticle-based vaccine delivery system containing adjuvant
CN114728154A (zh) 基于丝素蛋白的微针及其用途
WO2021233237A1 (zh) 一种肿瘤疫苗及其制备方法和应用
TR201904758T4 (tr) İmmünoterapiye yönelik RNA formülasyonu.
EP1146858A1 (en) Non-invasive vaccination through the skin
KR20140043348A (ko) 리포솜 제제
JP2021512142A5 (https=)
CN112118847A (zh) 包含突变kras序列和脂质的化合物及其用途
US20030118550A1 (en) Compositions and methods for inducing activation of dendritic cells
JPWO2022123070A5 (https=)
CN118055775A (zh) 包括hsp90抗原肽的抗癌用疫苗组合物及其用途
SINGH et al. Vesicular systems for non-invasive topical immunization: rationale and prospects
US20220062383A1 (en) Regulation of a foreign body response
US20250235532A1 (en) Polymer-lipid hybrid nanoparticles comprising a lipid and a block copolymer as well as methods of making and uses thereof
US20250170236A1 (en) A novel cationic adjuvant composition
EP1029549B1 (en) Formulation of nucleic acids and acemannan
WO2001083698A2 (en) Compositions and methods for inducing activation of dendritic cells
Misra et al. Vaccine Design, Nanoparticle Vaccines and Biomaterial Applications
WO2024186646A1 (en) Methods of making lipid adjuvanted compositions
EP4281105A1 (en) Composition for immune tolerance induction and use in gene therapy
WO2026012340A1 (zh) CpG1018/1826/007/2006联合MNR的组合物用于治疗胰腺癌
WO2024207942A1 (zh) 一种肿瘤疫苗佐剂及其应用
Kılıç Therapeutic Potential of an Immunosuppressive Oligodeoxynucleotide Encapsulated within Liposomes on Bleomycin-Induced Mouse Model of Lung Inflammation and Fibrosis